Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study
1 other identifier
interventional
22
1 country
1
Brief Summary
The purpose of this study is to compare two different techniques of mastopexy with autologous augmentation, the Lower Pole Subglandular Advancement Mastoplasty (LOPOSAM) and Rubins Mastopexy with autologous augmentation, in massive weight loss patients to see if one technique is superior to the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 3, 2015
CompletedFirst Posted
Study publicly available on registry
October 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2017
CompletedAugust 22, 2018
August 1, 2018
2.2 years
October 3, 2015
August 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Operation Time
The time of surgery from start to finish is registered for both techniques.
Intraoperative
Secondary Outcomes (4)
Costs of treatment
1 year
Breast measurements
1 year
Cosmetic result
1 year
Complications
3 months
Study Arms (2)
Rubins Mastopexy
ACTIVE COMPARATORPatients are allocated to a mastopexy using Rubins technique
LOPOSAM
ACTIVE COMPARATORPatients are allocated to a mastopexy using the LOPOSAM technique
Interventions
The surgical technique described by Rubin is performed. No other intervention.
Eligibility Criteria
You may qualify if:
- Women that meet the Danish National Board of Health criteria for post bariatric surgery, and is found to be a suitable candidate for autologous augmentation
You may not qualify if:
- Severe dementia, making informed consent impossible
- Non-Danish speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Odense University Hospital, Department of Plastic and Reconstructive Surgery
Odense C, 5000, Denmark
Related Publications (10)
Rubin JP. Mastopexy after massive weight loss: dermal suspension and total parenchymal reshaping. Aesthet Surg J. 2006 Mar-Apr;26(2):214-22. doi: 10.1016/j.asj.2006.01.010.
PMID: 19338902BACKGROUNDRubin JP, Khachi G. Mastopexy after massive weight loss: dermal suspension and selective auto-augmentation. Clin Plast Surg. 2008 Jan;35(1):123-9. doi: 10.1016/j.cps.2007.08.008.
PMID: 18061806BACKGROUNDGusenoff JA, Rubin JP. Plastic surgery after weight loss: current concepts in massive weight loss surgery. Aesthet Surg J. 2008 Jul-Aug;28(4):452-5. doi: 10.1016/j.asj.2008.06.001.
PMID: 19083561BACKGROUNDRubin JP, Gusenoff JA, Coon D. Dermal suspension and parenchymal reshaping mastopexy after massive weight loss: statistical analysis with concomitant procedures from a prospective registry. Plast Reconstr Surg. 2009 Mar;123(3):782-789. doi: 10.1097/PRS.0b013e31819ba1a8.
PMID: 19319040BACKGROUNDThoma A, Kaur MN, Tsoi B, Ziolkowski N, Duku E, Goldsmith CH. Cost-effectiveness analysis parallel to a randomized controlled trial comparing vertical scar reduction and inverted T-shaped reduction mammaplasty. Plast Reconstr Surg. 2014 Dec;134(6):1093-1107. doi: 10.1097/PRS.0000000000000751.
PMID: 25255113BACKGROUNDHansson E, Manjer J, Ringberg A. Inter-observer reliability of clinical measurement of suprasternal notch-nipple distance and breast ptosis. Indian J Plast Surg. 2014 Jan;47(1):61-4. doi: 10.4103/0970-0358.129625.
PMID: 24987206BACKGROUNDPusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-353. doi: 10.1097/PRS.0b013e3181aee807.
PMID: 19644246BACKGROUNDFischer JP, Cleveland EC, Shang EK, Nelson JA, Serletti JM. Complications following reduction mammaplasty: a review of 3538 cases from the 2005-2010 NSQIP data sets. Aesthet Surg J. 2014 Jan 1;34(1):66-73. doi: 10.1177/1090820X13515676. Epub 2013 Dec 13.
PMID: 24334499BACKGROUNDCardoso MJ, Cardoso JS, Wild T, Krois W, Fitzal F. Comparing two objective methods for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat. 2009 Jul;116(1):149-52. doi: 10.1007/s10549-008-0173-4. Epub 2008 Sep 7.
PMID: 18777134BACKGROUNDGodwin Y, Barron EJ, Edmunds MC, Meyer M, Bardsley A, Logan AM, O'Neill TJ, Wood SH. A comparison of the patient and surgeon opinion on the long-term aesthetic outcome of reduction mammaplasty: have we improved over 15 years? J Plast Reconstr Aesthet Surg. 2014 Jul;67(7):932-8. doi: 10.1016/j.bjps.2014.04.006. Epub 2014 May 9.
PMID: 24860932BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peder Ikander, MD
Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 3, 2015
First Posted
October 8, 2015
Study Start
September 1, 2015
Primary Completion
November 16, 2017
Study Completion
November 16, 2017
Last Updated
August 22, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share